Regence GLP-1 Coverage: Wegovy & Zepbound Rules in WA, OR, ID & UT

How Regence coverage actually works

Regence is the Blue Cross Blue Shield licensee for Washington, Oregon, Idaho, and Utah — four states, one company, but coverage decisions still split by plan type. Your employer's plan decides whether anti-obesity medications are a covered benefit at all; Regence administers whatever the plan sponsor chose. That's why two Regence members get opposite answers on Wegovy.

The diabetes-vs-weight-loss split

The single most important distinction: diabetes-indicated GLP-1s (Ozempic, Mounjaro) have far better coverage than weight-loss-indicated ones (Wegovy, Zepbound). If you have type 2 diabetes, coverage is much more likely — usually after metformin. Without diabetes, you're at the mercy of whether the plan opted into anti-obesity coverage at all. See BCBS GLP-1 coverage overview and Anthem coverage.

Typical prior authorization checklist

• BMI 30+, or 27+ with a documented comorbidity (hypertension, sleep apnea, T2D, dyslipidemia).
• Documented lifestyle program — often 3-6 months of diet/exercise attempts on record.
• Letter of medical necessity from the prescriber.
• Step therapy — some plans require trying other agents or metformin first.
• Specialist requirement — certain plans want the prescription from an obesity-medicine or endocrine provider.

For the full process, see prior authorization guide and appeal playbook.

When the plan excludes weight-loss drugs entirely

Many Regence employer plans simply exclude anti-obesity medications — no amount of documentation changes an exclusion. The realistic cash path: LillyDirectfor Zepbound ($299-449), NovoCare for Wegovy ($299-499), orcompounded semaglutide via licensed telehealth from $119/month.

Frequently asked questions

Does Regence cover Wegovy or Zepbound for weight loss?

It depends on your specific plan — Regence is the BCBS licensee for Washington, Oregon, Idaho and Utah, and weight-loss drug coverage is an employer/plan-level decision. Many Regence commercial plans exclude anti-obesity medications entirely; when covered, prior authorization with BMI 30+ (or 27+ with comorbidity) is standard.

Does Regence cover Ozempic or Mounjaro?

Yes, more often — but for type 2 diabetes, not weight loss. Ozempic and Mounjaro are diabetes-indicated drugs; coverage typically requires a diabetes diagnosis and step therapy through metformin first. Using them off-label for weight loss without a diabetes diagnosis usually gets denied.

What are Regence's prior authorization requirements for GLP-1s?

Typical Regence PA criteria for weight-loss GLP-1s: BMI 30+ or 27+ with a weight-related condition, documented participation in a lifestyle program (often 3-6 months), prescriber documentation of medical necessity, and sometimes step therapy through other agents first.

What if Regence denies my GLP-1 prior authorization?

Appeal — Regence denials are often overturned with proper documentation: comorbidity records, lifestyle-program proof, and a letter of medical necessity. If the plan simply excludes weight-loss drugs (common on employer plans that didn't opt in), no appeal wins — the fix is cash-pay: LillyDirect for Zepbound ($299-499) or compounded semaglutide ($119-299).

Does Regence cover compounded semaglutide?

No — no commercial insurer covers compounded GLP-1s. Compounded products are always cash-pay, which is why telehealth programs bundle them at $119-299/month as the uninsured fallback.

Bottom line

Regence coverage splits on two questions: does your plan include weight-loss drugs, and is your use diabetes or obesity? If both answers go your way, PA is paperwork; if not, compounded semaglutide from $119/month is the fastest uninsured route.